NDC 0169-7830

NOVOEIGHT

(antihemophilic Factor, Recombinant)

NOVOEIGHT is a Kit in the Plasma Derivative category. It is labeled and distributed by Novo Nordisk. The primary component is .

• Product ID: 0169-7830_06e8d3b7-2e27-43f6-8e97-34cf0bc7e884
• NDC: 0169-7830
• Product Type: Plasma Derivative
• Proprietary Name: NOVOEIGHT
• Generic Name: (antihemophilic Factor, Recombinant)
• Dosage Form: Kit
• Marketing Start Date: 2015-04-01
• Marketing Category: BLA / BLA
• Application Number: BLA125466
• Labeler Name: Novo Nordisk
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0169-7830-01

1 KIT in 1 KIT (0169-7830-01) * 4 mL in 1 VIAL, GLASS (0169-7831-11) * 4 mL in 1 SYRINGE, GLASS (0169-7008-98)

• Marketing Start Date: 2015-04-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0169-7830-01 [00169783001]

NOVOEIGHT KIT

• Marketing Category: BLA
• Application Number: BLA125466
• Product Type: PLASMA DERIVATIVE
• Billing Unit: EA
• Marketing Start Date: 2015-04-01

Drug Details

NDC Crossover Matching brand name "NOVOEIGHT" or generic name "(antihemophilic Factor, Recombinant)"

NDC	Brand Name	Generic Name
0169-7810	NOVOEIGHT	(antihemophilic factor, recombinant)
0169-7815	NOVOEIGHT	(antihemophilic factor, recombinant)
0169-7820	NOVOEIGHT	(antihemophilic factor, recombinant)
0169-7825	NOVOEIGHT	(antihemophilic factor, recombinant)
0169-7830	NOVOEIGHT	(antihemophilic factor, recombinant)
0169-7850	NOVOEIGHT	(antihemophilic factor, recombinant)